80029084: 12th Annual Current Topics in Gastrointestinal and Liver Pathology

LOCATION CHANGE:
Due to water damage in the David H. Koch Cancer Research Building from Hurricane Sandy, this activity has been relocated to the Chevy Chase Bank Conference Center in The Sheikh Zayed Tower of The Johns Hopkins Hospital, 1800 Orleans Street, Main Level, Baltimore, Maryland 21287.

ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 14.75 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER CREDITAmerican Board of Pathology (SAM)
This course is approved for self assessment module (SAM) credit by the American Board of Pathology and addresses the ACGME competencies of Medical Knowledge and Systems-Based Practice.

Contact Hours for Non-Physicians
The Johns Hopkins University has approved this activity for 14.75 contact hours for non-physicians.

DESCRIPTION

This 12th annual conference is intended as a practical overview for pathologists who encounter gastrointestinal and liver specimens in daily practice. Interpretation of biopsies of the upper GI tract mucosa and the liver will be addressed, as well as recent advances in pancreatic and biliary pathology. Case presentation will be featured to emphasize presented concepts. Participants should come away with a better understanding of interpretation of mucosal biopsies, liver biopsies, pancreatic/biliary disorders, current concepts in staging and the application of modern techniques to gastrointestinal disorders.

OBJECTIVES

After attending this activity, the participant will demonstrate the ability to:

Talks

Welcome and Conference Goals

Controversies in the Diagnosis of Barrett and Barrett-Related Dysplasia

1. discuss the criteria for rendering a diagnosis of Barrett esophagus in the U.S.
2. explain the morphologic criteria and difficulties in diagnosing Barrett's related dysplasia
3. review the treatment options for superficial esophageal adenocarcinoma

Managing Esoteric Referral Testing

Describe the esoteric clinical laboratory tests that are used in the diagnosis and management of gastrointestinal diseases.
Examine the strengths and weaknesses of several commonly used esoteric tests.
Describe several strategies for managing requests for access to esoteric testing.

November 10, 20122:15 PM to 3:15 PM

Summarize the Basic Concepts in Digital Pathology and Image Analysis

Understand the basic components of digital pathology
Understand common applications of digital pathology
Recognize challenges to the implementation of digital pathology, including technical, workflow and regulatory challenges

Panel Discussion

Describe the management of esoteric referral testing, basic concepts in digital pathology and molecular testing in colon cancer.
Describe the application of emerging technologies to the practice of gastrointestinal pathology.

November 10, 20124:30 PM to 5:00 PM

Panel Discussion

Understand the basic components of digital pathology
Understand common applications of digital pathology
Recognize challenges to the implementation of digital pathology, including technical, workflow and regulatory challenges

November 10, 20124:30 PM to 5:00 PM

Panel Discussion

Assorted Small Intestinal Pathology Case Presentations

Recognize more common small bowel lymphomas and discuss their prognosis.
Recognize some common pitfalls in small intestinal pathology.
Describe types of neoplasms encountered on small intestinal samples.

Surgeon’s Perspective to the Pathological Evaluation of Total Mesorectal Excision Specimens

1. Assess qualiy of surgery of rectal cancer specimens
2. Understand the critical role of the pathologist in the treatment of rectal cancer patients
3. Interact with the surgeon and oncologist in the setting of the multidisciplinary team to achieve best treatment options

Fatty Liver Disease

Summary

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.